(Q34273115)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

meta-analysis

0 references

title

Statin use and risk of pancreatic cancer: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Yue Xie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Min Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jun Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Xiaoming Liao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jian Shen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Meng Shi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Wenjing Li

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Haoxuan Zheng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Bo Jiang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

5 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

published in

Cancer Causes & Control

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

1099-1111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10552-012-9979-9

31 January 2020

exact match

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Carcinogenicity of lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Common cardiovascular medications in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Differences in antitumor effects of various statins on human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statin use and cancer risk in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statins and pancreatic cancer risk: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statin use and the risk of pancreatic cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statins and cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Lipid-Lowering Medication and Risk of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Effect of statin therapy on colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Incidence of cancer and statin usage--record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statin use and the risk of 10 cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statin use and cancer risk: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statins and cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statins and cancer: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-012-9979-9

10.1007/S10552-012-9979-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22562222%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference